Predictive Oncology (POAI)
(Real Time Quote from BATS)
$0.85 USD
-0.03 (-3.42%)
Updated Sep 20, 2024 11:02 AM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Predictive Oncology Inc. [POAI]
Reports for Purchase
Showing records 1 - 10 ( 10 total )
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
PREDICTIVE Patient Drug Response at Preclinical Stage; Initiating With Buy and a $3 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Revenue Growth and Gross Margin Improvement Continue to Impress; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Acquisition advances patient centric therapies - Reiterate Buy and $5 PT
Provider: Litchfield Hills Research, LLC
Analyst: O'NEILL T
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Update for 3Q21 results - Reiterate Buy and $5 PT
Provider: Litchfield Hills Research, LLC
Analyst: O'NEILL T
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
AI Platform Makes Important Early Steps; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Capitalization Present a Promising Opportunity
Provider: Quantum Research Group, LLC
Analyst: Research Department
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Putting PeDAL to the Drug Discovery Mettle; Initiating Coverage With a Buy Rating and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
|